Sexual dysfunction is underrecognized in patients with migraine: A systematic review and meta-analysis
Abstract
OBJECTIVE
This study aimed to summarize and pool the existing observational evidence on sexual dysfunction (SD) in patients with migraine and to explore sex-specific associations.
BACKGROUND
SD appears to be more common in patients with migraine, yet the available data are heterogeneous and scattered, with most research focused on women. A comprehensive synthesis across both sexes has been lacking.
METHODS
This systematic review and meta-analysis of observational studies identified relevant studies reporting data on SD published between July 1987 and July 2025 were identified through searches in PubMed, Scopus, Embase, the Cochrane Library, and Google Scholar.
RESULTS
Twenty-one studies including 1692 patients with migraine and 741 controls were identified; nine studies were qualified for quantitative analysis. Reported SD prevalence ranged from 41.8% to 91.0% among women and from 46.6% to 80.0% among men. Across controlled studies, patients with migraine showed a higher likelihood of experiencing SD compared with healthy controls (odds ratio [OR], 6.13; 95% confidence interval [CI], 1.59-23.60). In women, the likelihood of SD was more than three times higher (OR, 3.65; 95% CI, 1.22-10.9). Data for men were limited to two small, controlled studies, both indicating higher SD rates among male patients with migraine (OR, 164.85; 95% CI, 21.09-1288.89). When studies with extreme values were excluded, the association between migraine and SD remained still elevated.
CONCLUSIONS
SD…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,692 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.